A Five-Year Trend Analysis of USFDA Expedited Approvals and Designations for New Drug Applications (2020–2024)
Crossref DOI link: https://doi.org/10.1007/s12247-026-10399-z
Published Online: 2026-02-03
Published Print: 2026-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gadekar, Kailas Vijay
Joga, Ramesh
Yerram, Sravani
Waiker, Sonali
Srivastava, Saurabh
Text and Data Mining valid from 2026-02-03
Version of Record valid from 2026-02-03
Article History
Received: 10 October 2025
Accepted: 16 January 2026
First Online: 3 February 2026
Declarations
:
: The authors declare no competing interests.